It’s been that kind of day on the markets, with a relief rally shaping up on both sides of the border, out of hope the death tolls from the coronavirus have leveled off.
Everything, it seems, is positive, with all sectors finding happy stories on which to draw. In particular, health-care companies jumped 5.9% in Toronto and 4.1% in New York
One of the beneficiaries of these stories is one familiar to users of this site. Monday, Montreal-based Relevium Technologies Inc. (TSX-Venture:RLV) announced today that a pre-order platform where customers can purchase in advance and reserve its new line of Cleancare hand sanitizers by Bioganix.
Relivium will begin accepting pre-orders for the company’s new Cleancare hand sanitizer products and will be shipped out to customers on a first come first serve basis. The company expects the product to be available eight weeks from now and expect this format to be in high demand. The Company will prioritize existing customers in the United States.
The company will begin its initial pre-order with approximately 10,000 units and will actively scale up operations to meet market demand.
Shares in RLV added a penny, or 18.2%, to 6.5 cents, on volume of 12.8 million shares.
Stateside, Marietta, Ga.-based MiMedx (OTC:MDXG) saw its shares push forward on word it has finalized a settlement with the U.S. Department of Justice related to the accuracy of its commercial pricing disclosures to the U.S. Department of Veterans Affairs pertaining to one of its products listed on the Federal Supply Schedule.
Without admitting guilt, the company has agreed to pay $6.5 million to resolve the matter.
The company, an industry leader in advanced wound care and an emerging therapeutic biologics company, has been mired in legal troubles since 2017 when several whistleblowers claimed that the company was channel stuffing product in order to meet its sales goals. The company subsequently had to restate certain financial statements and fired a number of senior executives including former CEO Pete Petit.
MDXG shares galloped 31 cents, or 9.7%, to $3.51, on volume of 187,000.
